Results 21 to 30 of about 218,075 (284)

Screening for SARS-COV-2 Using RT-qPCR in Patients with Hematologic Neoplasms Receiving Chemotherapy

Prague Medical Report, 2023
It has been recommended that patients with leukaemias and lymphomas undergo universal screening for SARS-COV-2 using RT-qPCR before each treatment on the grounds of their high risk of experiencing severe forms of COVID-19.
Ignacio Martín Santarelli, Mariela Sierra, Sofía Isabel Fernández   +2 more
doaj   +1 more source

The Role of TET2 in Hematologic Neoplasms [PDF]

Cancer Cell, 2011
TET2 encodes an enzyme that hydroxylates methylcytosine and is frequently targeted by loss-of-function mutations in myelodysplasia, myeloproliferative disorders, and acute myeloid leukemia. In this issue of Cancer Cell, two studies show that inactivation of Tet2 enhances hematopoietic stem cell self renewal and promotes the development of ...
Holmfeldt, Linda, Mullighan, Charles G.
openaire   +2 more sources

Immunotherapy in Pediatric Hematologic Malignant Neoplasms

Clinical Pediatric Hematology-Oncology, 2020
Childhood acute leukemia has achieved tremendous treatment outcome improvement over the past several decades. Given that pediatric leukemia remains the most common type of childhood malignant tumors, there are still unmet needs in relapsed/refractory ...
Kyung Taek Hong
doaj   +1 more source

Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH.

, 2021
20.500.12530/87854Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement.
Garcia-Gutierrez, V, Gonzalez-Calle, V, Gonzalez-Porras, J R, Lecumberri, R, Reverter, J C, Mateo, J, Marco, P   +6 more
core   +1 more source

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

Nature Communications, 2023
Genomic profiling of hematologic malignancies has augmented our understanding of variants that contribute to disease pathogenesis and supported development of prognostic models that inform disease management in the clinic.
Ryan N. Ptashkin, Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao, Jacklyn Casanova, Yun-Te David Lin, Kseniya Petrova-Drus, Abhinita S. Mohanty, Ruben Bacares, Jamal Benhamida, Satshil Rana, Anna Razumova, Chad Vanderbilt, Anoop Balakrishnan Rema, Ivelise Rijo, Julie Son-Garcia, Ino de Bruijn, Menglei Zhu, Sean Lachhander, Wei Wang, Mohammad S. Haque, Venkatraman E. Seshan, Jiajing Wang, Ying Liu, Khedoudja Nafa, Laetitia Borsu, Yanming Zhang, Umut Aypar, Sarah P. Suehnholz, Debyani Chakravarty, Jae H. Park, Omar Abdel-Wahab, Anthony R. Mato, Wenbin Xiao, Mikhail Roshal, Mariko Yabe, Connie Lee Batlevi, Sergio Giralt, Gilles Salles, Raajit Rampal, Martin Tallman, Eytan M. Stein, Anas Younes, Ross L. Levine, Miguel-Angel Perales, Marcel R. M. van den Brink, Ahmet Dogan, Marc Ladanyi, Michael F. Berger, A. Rose Brannon, Ryma Benayed, Ahmet Zehir, Maria E. Arcila   +54 more
doaj   +1 more source

Survival of European patients diagnosed with lymphoid neoplasms in 2000–2002: results of the HAEMACARE project

Haematologica, 2011
Background The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set up to improve the availability and standardization of data on hematologic malignancies in Europe, used the European Cancer Registry-based project on ...
Rafael Marcos-Gragera, Claudia Allemani, Carmen Tereanu, Roberta De Angelis, Riccardo Capocaccia, Marc Maynadie, Stefano Luminari, Stefano Ferretti, Tom Børge Johannesen, Risto Sankila, Marja-Liisa Karjalainen-Lindsberg, Arianna Simonetti, Maria Carmen Martos, Martine Raphaël, Pilar Giraldo, the HAEMACARE Working Group, Milena Sant   +16 more
doaj   +1 more source

An intriguing coexistence of cutaneous and systemic mastocytosis with atypical chronic myeloid leukemia: An associated hematologic neoplasm (SM-AHN)

Journal of Applied Hematology, 2021
Systemic mastocytosis (SM) characterized by focal or diffuse infiltrates of neoplastic mast cells can range from indolent cutaneous disease to aggressive systemic disease.
B R Rajalakshmi, Vijaya Basavaraj
doaj   +1 more source

Myelodysplastic/Myeloproliferative Neoplasms [PDF]

, 2018
The myelodysplastic syndrome-myeloproliferative neoplasms (MDS/MPNs) are a heterogeneous group of hematologic malignancies characterized by dysplastic and myeloproliferative clinical, laboratory, and morphological overlapping features, both in marrow and
Yves Chalandon, Yves Chalandon., Francesco Onida   +2 more
core   +1 more source

Female Genital Tract Involvement in Acute Lymphoblastic Leukemia: A Rare Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2016
Female Genital Tract (FGT) involvement with hematologic neoplasms is uncommon and the hematologic malignancies which involve the female genital organs are usually non-Hodgkin’s lymphoma.
Vikram Narang, Amit Dhiman, Bhavna Garg, Neena Sood   +3 more
doaj   +1 more source

Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort study

Cancer Medicine, 2023
Background Plasma cell neoplasms are a group of hematologic neoplasms that often develop in the elderly population. The relationship between cholesterol levels and hematologic malignancy has been identified in population studies.
Linfeng Li, Zhengyu Yu, Jianjun Ren, Ting Niu   +3 more
doaj   +1 more source